Cargando…
Anti-inflammatory and Immune Therapy for Alzheimer's Disease: Current Status and Future Directions
From the initial characterizations of inflammatory responses in Alzheimer’s disease (AD) affected brains, namely the demonstration of activated microglia and reactive astrocytes, complement system activation, increased production of proinflammatory cytokines, and evidence for microglial-produced neu...
Autores principales: | Walker, Douglas, Lue, Lih-Fen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644496/ https://www.ncbi.nlm.nih.gov/pubmed/19305740 http://dx.doi.org/10.2174/157015907782793667 |
Ejemplares similares
-
Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?
por: Lue, Lih-Fen, et al.
Publicado: (2012) -
Alzheimer’s Disease Research Using Human Microglia
por: Lue, Lih-Fen, et al.
Publicado: (2019) -
Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
por: Lue, Lih-Fen, et al.
Publicado: (2017) -
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains
por: Walker, Douglas G., et al.
Publicado: (2015) -
Secretory PLA(2)-IIA: a new inflammatory factor for Alzheimer's disease
por: Moses, Guna SD, et al.
Publicado: (2006)